Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.3991
+0.104235.33%
Post-market: 0.44830.0492+12.33%19:59 EDT
Volume:80.85M
Turnover:31.61M
Market Cap:22.28M
PE:-0.62
High:0.4500
Open:0.2776
Low:0.2610
Close:0.2949
52wk High:1.55
52wk Low:0.1952
Shares:55.82M
Float Shares:54.40M
Volume Ratio:0.76
T/O Rate:148.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6401
EPS(LYR):-0.7437
ROE:-543.97%
ROA:-70.59%
PB:-6.22
PE(LYR):-0.54

Loading ...

Feb 04, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jan 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jan 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jan 31, 2020

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Jan 17, 2020

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 17, 2020

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Jan 13, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 17, 2019

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Dec 13, 2019

Major Issues Report

Current report, item 3.01
Dec 11, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Dec 11, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Dec 03, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 25, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 14, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 06, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 29, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 22, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 03, 2019

Major Issues Report

Current report, items 8.01 and 9.01